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Cellular reverse transcriptase-related (rvt) genes represent a novel class of reverse transcriptases 
(RTs), which are only distantly related to RTs of retrotransposons and retroviruses, but, similarly to 
telomerase RTs, are immobilized in the genome as single-copy genes. They have been preserved by 
natural selection throughout the evolutionary history of large taxonomic groups, including most fungi, 
a few plants and invertebrates, and even certain bacteria, being the only RTs present across different 
domains of life. Bacterial rvt genes are exceptionally rare but phylogenetically related, consistent with 
common origin of bacterial rvt genes rather than eukaryote-to-bacteria transfer. To investigate 
biochemical properties of bacterial RVTs, we conducted in vitro studies of recombinant HaRVT 
protein from the filamentous gliding bacterium Herpetosiphon aurantiacus (Chloroflexi). Although 
HaRVT does not utilize externally added standard primer-template combinations, in the presence of 
divalent manganese it can polymerize very short products, using dNTPs rather than NTPs, with a 
strong preference for dCTP incorporation. Further, we investigated the highly conserved N- and C-
terminal domains, which distinguish RVT proteins from other RTs. We show that the N-terminal 
coiled-coil motif, which is present in nearly all RVTs, is responsible for the ability of HaRVT to 
multimerize in solution, forming up to octamers. The C-terminal domain may be capable of protein 
priming, which is abolished by site-directed mutagenesis of the catalytic aspartate and greatly reduced 
in the absence of the conserved tyrosine residues near the C-terminus. The unusual biochemical 
properties displayed by RVT in vitro will provide the basis for understanding its biological function in 
vivo.  
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Reverse transcription, i.e. polymerization of DNA on RNA templates, is a process characteristic 
of retrotransposons and reverse-transcribing viruses, which is performed by a group of enzymes called 
reverse transcriptases (RTs) (Eickbush and Jamburuthugoda 2008; Garfinkel, et al. 2016; Menendez-
Arias, et al. 2017). It is generally believed that RTs have no specific function in host cells, since all of 
them originate from “selfish” mobile genetic elements, with the notable exception of telomerase 
reverse transcriptases (TERTs). TERTs can add short G-rich repetitive sequences to telomeres, 
thereby protecting the ends of linear chromosomes in eukaryotic cells (see (Lue and Autexier 2006; 
Arkhipova 2012) for review). They are usually encoded by single-copy genes, and do not increase in 
copy numbers, as do mobile elements. In 2011, we described another group of non-mobile cellular 
RTs (Gladyshev and Arkhipova 2011), named reverse transcriptase related (rvt) genes. While rvt 
genes were initially found in bdelloid rotifers Adineta vaga and Philodina roseola (phylum Rotifera, 
class Bdelloidea), a search of genome databases revealed that rvt genes are widespread and can be 
found in all kingdoms of life, albeit with patchy distribution. Finding the same type of RT in both 
prokaryotes and eukaryotes is so far unprecedented, and implies a function that should be applicable 
to both. In each host species, rvt is present either as a single-copy gene or as a gene family consisting 
of two or three members (Gladyshev and Arkhipova 2011). The overall structure of rvt-encoded 
proteins is highly conserved and significantly deviates from other RT types, especially in the N- and 
C-terminal regions, with the coiled-coil at the N-termini being the only recognizable motif other than 
RT (Gladyshev and Arkhipova 2011). 
The rvt genes evolve under purifying selection, and were shown to contain spliceosomal introns 
in many eukaryotic lineages. Most are transcriptionally active; however, they may also undergo decay, 
pseudogenization, and loss. The purified NcRVT protein from the model filamentous fungus 
Neurospora crassa (phylum Ascomycota) is enzymatically active, and in the presence of Mn2+ can 
polymerize both dNTPs and NTPs with strong preference for the latter, exhibiting terminal transferase 
activity (Gladyshev and Arkhipova 2011). However, NcRVT was unable to perform canonical RNA-
dependent DNA polymerization with standard exogenous template-primer combinations, as might be 
4 
 
expected from its sequence similarity to other RTs. Therefore, it was of interest to examine a 
representative from another kingdom, so that their properties could be compared directly. 
Here, we investigate biochemical properties of the recombinant RVT protein of bacterial origin 
and compare it with its fungal counterpart, with special emphasis on the N- and C-terminal domains 
that distinguish RVTs from all other RTs. We find that it forms multimers in solution, and 
demonstrate that the N-terminal domain is directly responsible for its multimerization. We further 
show that RVT may employ protein priming to initiate polymerization, adding to the list of unusual 
properties of these enigmatic enzymes. Finally, we determine the nucleotide specificity of the 
bacterial enzyme, which displays a strong preference for dCTP incorporation, while showing little or 
no affinity for NTPs as opposed to dNTPs.  
Materials and methods 
Bacterial strains and growth conditions 
Herpetosiphon aurantiacus DSM 785 (strain: ATCC 23779) was obtained from ATCC. H. 
aurantiacus was grown on CY-agar medium at 25ºC for 3-5 days. Escherichia coli Rosetta 2 (DE3) 
strain (Novagen) was used for expression of recombinant proteins. In all other cases, E. coli NEB5α 
(NEB) and Zymo5α (Zymo Research) chemically competent cells were used for transformation and 
plasmid propagation. 
DNA manipulations 
Genomic DNA from H. aurantiacus was extracted using UltraClean® Microbial DNA Isolation 
Kit (MoBio Labs). The rvt gene amplified by PCR was cloned into pET45b vector (Novagen) using 
BstBI and XhoI sites. The obtained construct carrying the N-terminal 6xHis tag (pEAG87, encoding 
HaRVT-N) was used to create a construct without the tag, followed by PCR-based ligation to 
introduce a C-terminal His-tag, yielding pEAG93 (HaRVT) (Table 1). All subsequent HaRVT 
mutants were obtained using GenEdit™ site-directed DNA mutagenesis kit (First Biotech). The 
resulting plasmids were verified by Sanger sequencing on the ABI3730XL at the W. M. Keck 
Ecological and Evolutionary Genetics Facility at the Marine Biological Laboratory. Secondary 
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structure predictions were done by Phyre2 (Kelley and Sternberg 2009) in the intensive modelling 
mode. All recombinant HaRVT protein variants obtained in this study are listed in Table 1. 
Protein expression and visualization 
NcRVT protein was obtained as described in (Gladyshev and Arkhipova 2011). Recombinant 
HaRVT versions were expressed in E. coli Rosetta 2 (DE3) in LB medium, Miller formulation 
(Amresco) supplied with 100 µg/ml ampicillin (Sigma), 34 µg/ml chloramphenicol (Acros Organic) 
and 660 mM D-sorbitol (Amresco). First, cells were grown at 37ºC, 200 rpm until OD=0.6. After that, 
expression of recombinant proteins was induced by supplying the growth medium with IPTG to 500 
µM (Gold Bio), and the culture was grown for additional 4 h at 31ºC, 250 rpm. Bacterial cells were 
pelleted by centrifugation at 4ºC, 4000 g for 30 min and stored at -80ºC. Induction of recombinant 
proteins was confirmed by SDS-PAGE followed by Western blot hybridization.  
SDS-PAGE was carried out in Mini-PROTEAN Tetra cell system (Bio-Rad) with Tris-Glycine 
buffer. Polyacrylamide 8-10% gels for protein separation were cast manually from custom-made 
solutions. After electrophoresis, proteins were visualized using Coomassie-based InstantBlue Protein 
Stain (Expedeon) or GelCode™ Blue Stain Reagent (Thermo Scientific), and gels were scanned either 
on Epson Perfection V500 scanner or using Amersham Imager 600 system (GE Healthcare). Western 
blotting was performed to PVDF membranes Amersham Hybond P (GE Healthcare) using wet 
transfer method. Membranes were incubated with the primary His-tag specific antibody (Aviva 
Systems Biology, OAEA00010, RRID:AB_10874637) at 1:5000 dilution and the secondary goat anti-
mouse IgG-HRP (Santa Cruz Biotechnology, sc-2005, RRID:AB_631736) antibody at 1:10,000 
dilution. His-tagged proteins were detected with SuperSignal West Dura Extended Duration Substrate 
(Thermo Scientific) using either blue sensitive X-ray film Amersham Hyperfilm ECL (GE 
Healthcare), or the Amersham Imager 600 chemiluminescence imager (GE Healthcare). 
Protein purification 
Lysates were prepared in lysis buffer (50 mM phosphate buffer, 300 mM NaCl, pH 7.0) for 
metal-affinity chromatography, or in buffer A (50 mM Tris-HCl, 100 mM NaCl, 1:1000 2-
Mercaptoethanol, pH 7.5) for sucrose gradient separation; both were supplemented with Roche 
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cOmplete™ EDTA-free Protease Inhibitor Cocktail (Sigma) according to manufacturer’s instructions. 
Frozen cell pellets containing induced protein were thawed in the respective buffer and sonicated on 
ice (10 s followed by 30-s pause for 3 times). Soluble proteins were separated from insoluble debris 
by centrifugation at 4ºC, 4000 g for 30 min.  
Recombinant proteins were purified using Co2+-based immobilized metal affinity 
chromatography (IMAC). We used HisTALON™ Gravity Column Purification Kit (Clontech) for 
HaRVT and TALON® Single Step Columns (Clontech) for other HaRVT mutant versions, following 
the manufacturers’ protocols. Roche cOmplete™ EDTA-free Protease Inhibitor Cocktail (Sigma) was 
added to all buffers. Purified proteins were stored at 4ºC. 
Analysis of oligomeric states 
The bacterial lysate (2 ml) containing soluble proteins was loaded on top of a sucrose gradient 
made from 17 ml of 40% sucrose and 20 ml of 15% sucrose, with both stock solutions prepared in 
buffer A (50 mM Tris-HCl, 100 mM NaCl, pH 7.5) supplied with 1:1000 2-Mercaptoethanol. 
Gradients were centrifuged in a SW 32 Ti swinging bucket rotor (Beckman) for 24 h at 4ºC, 30,000 
rpm. 1-ml fractions were collected with a peristaltic pump (Bio-Rad), starting from the bottom of each 
tube. Fractions were analyzed by SDS-PAGE followed by staining with GelCode™ Blue Stain 
Reagent (Thermo Scientific), and/or Western blotting with the above His-tag specific antibody. 
Thyroglobulin from bovine thyroid (Sigma), alcohol dehydrogenase from Saccharomyces cerevisiae 
(Sigma), catalase from bovine liver (Sigma), and bovine serum albumin (NEB) dissolved or diluted in 
buffer A were used as references to create a standard curve of protein size vs. the number of protein-
containing fractions. We used R linear model function to estimate the size of HaRVT protein 
complexes. Coiled coil formation was predicted by PCOILS in the MPI toolkit (Alva, et al. 2016) 
using MTIDK matrix with weighting. 
In vitro activity assays 
For activity assays, proteins, either as purified HaRVT (0.5-3 µg) or as sucrose gradient fractions 
containing RVT variants (50-100 µg total protein), were mixed in a 10-µl reaction with 1 mCi/ml [α-
32P]dCTP (PerkinElmer) in buffer A (50 mM Tris-HCl, 100 mM NaCl, pH 7.5) supplied with 3 mM 
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MnCl2, and incubated as a master-mix for 1 h at 25ºC. Aliquots were then placed in tubes with 1 µl of 
respective chases, i.e. NTPs/dNTPs 10 mM each nucleotide, or nuclease-free water, and incubated for 
1 h at 25ºC. Nucleic acids were selectively removed, as needed, by treatment with 2 U of DNase I 
(NEB) or 10 U of RNase ONE™ Ribonuclease (Promega) at 37ºC for 30 min, or with 0.3 M NaOH at 
65ºC for 20 min. After incubation, all reactions were supplied with 0.6 units of Proteinase K (Thermo 
Scientific) and incubated at 53ºC for 2 h or overnight. Loading buffer (95% formamide, 5 mM EDTA, 
0.025% Bromophenol blue, 0.025% Xylene cyanol FF) was added to each reaction, followed by 
denaturation at 95ºC for 3 min. Reactions were separated on 12% or 20% denaturing PAGE in 1x 
TBE buffer (89 mM Tris-borate, 2 mM EDTA, pH 8.3). The gel percentage in each case was chosen 
based on the expected product size. Radioactive signals were detected using a storage phosphor 
imaging system Storm 860 (Amersham) or Typhoon FLA 7000 (GE Healthcare). A linear relationship 
between signal and image intensity was used in all cases. 
To assay HaRVT nucleotide preference, a master mix was prepared as follows: purified 
recombinant HaRVT (1 µg) was mixed in a 10-µl reaction with 1 mCi/ml [α-32P]dCTP or [α-32P]UTP 
in 1x priming buffer (50 mM Tris-HCl, 50 mM KCl, 1 mM DTT, pH 8.0) supplied with 3 mM MnCl2. 
After incubation at 25ºC for 30 min, an aliquot from each reaction was transferred to a tube containing 
1 µl of the respective 10 mM nucleotide, or control nuclease-free water, and incubated at 25ºC for 1 h. 
Reactions were treated with 0.6 U Proteinase K, denatured in formamide buffer, and separated on 
20% denaturing PAGE. Typhoon FLA 7000 (GE Healthcare) was used to detect 32P-labeled products. 
In the trans-complementation assay, amounts of HaRVT proteins were equalized according to 
Western hybridization data. In the reaction containing both Ha-D484A and Ha-YF, the amount of 
each protein mutant was the same as in reaction with respective mutant alone. Proteins were incubated 
with [α-32P]dCTP in 1x priming buffer (50 mM Tris-HCl, 50 mM KCl, 1 mM DTT, pH 8.0) supplied 
with 3 mM MgCl2 as described above. After incubation, reactions were mixed with 5x SDS-PAGE 
sample buffer (250 mM Tris-HCl, 5% SDS, 50% glycerol, 250 mM DTT, 0.01% bromophenol blue, 
pH 6.8, 1 mM PMSF), boiled for 3 min, separated on 10% SDS-PAGE, stained with InstantBlue, 
scanned, dried and phosphor imaged. 
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Assays of protein-nucleic acid linkage 
RVT was incubated with [α-32P]dCTP or [α-32P]UTP in 1x priming buffer (50 mM Tris-HCl, 50 
mM KCl, 1 mM DTT, pH 8.0) supplied with 3 mM MgCl2 or 3 mM MnCl2 as described above. After 
incubation, reactions were mixed with 5x SDS-PAGE sample buffer (250 mM Tris-HCl, 5% SDS, 
50% glycerol, 250 mM DTT, 0.01% bromophenol blue, pH 6.8, 1 mM PMSF), boiled for 3 min, 
separated on 10% SDS-PAGE, stained with InstantBlue, scanned, dried and phosphor imaged. For in-
gel analysis of nucleotide-amino acid linkage, reactions were separated on 10% SDS-PAGE, and the 
gels were treated with 1 M KOH at 65°C, as described in (Galligan, et al. 2011). 
Results 
rvt genes are exceedingly rare in bacteria but form a monophyletic clade 
The vast majority of rvt genes were found in fungal genomes, with filamentous ascomycetes 
displaying the highest degree of lineage diversification, and the only sequenced rvt-containing 
prokaryote being Herpetosiphon aurantiacus, a filamentous gliding bacterium (Gladyshev and 
Arkhipova 2011). Their highly sporadic occurrence in bacteria led to a suggestion that it may 
represent an exceptionally rare case of eukaryote-to-bacteria transfer. Following a huge increase in 
sequenced bacterial and eukaryotic genomes since 2011, we sought to re-examine their distribution in 
different domains of life. In the fungal kingdom, their presence can be traced to the earliest-branching 
fungi, such as blastocladiomycetes and chytrids (Fig. 1; expanded version, Supplementary Fig. S1). 
None were found in archaea, and still surprisingly few can be detected in bacteria. The diversity of 
representation across bacterial phyla has nevertheless increased: in addition to the phylum Chloroflexi 
(represented by Herpetosiphon aurantiacus, a closely related H. geysericola, and an environmental 
sequence from activated sludge), we found an intact rvt in the phylum Bacteroidetes (marine 
bacterium AO1-C), fragmented copies in the phyla Cyanobacteria (Scytonema tolypothrichoides, a 
terrestrial hydrophobic filamentous cyanobacterium), Planctomyces (Singulisphaera sp. GP187 from 
forest soil) and candidate phylum TM6 (bacterium UASB293 from upflow anaerobic sludge blanket 
reactor), and three highly similar transcripts of uncertain (possibly cyanobacterial) origin in a marine 
metatranscriptome sample. Interestingly, rvt sequences of bacterial origin are on average ~100 aa 
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shorter than their eukaryotic counterparts, and the conserved C-terminal domain lacks the 50-60-aa 
central part, which is present in all eukaryotic rvt genes. Phylogenetically, bacterial rvt genes, while 
highly diverse, form a clade (shown in Fig. 1 in cyan) that is separate from all eukaryotes, including 
fungi, rotifers, insects, and oomycetes, arguing against eukaryote-to-prokaryote transfer, and 
suggesting that their origin, which resulted from a successful combination of three domains (N-
terminal, core RT, and C-terminal), is very ancient and may in fact predate the prokaryotic-eukaryotic 
divide. If so, the degree of their loss from bacterial genomes must be quite unprecedented. 
Choice of expression system 
A conservation of biochemical properties, or lack thereof, could potentially illuminate the 
biological functions of RVT proteins, if a bacterial representative is compared with a known 
eukaryotic counterpart. In this study, we chose to focus on HaRVT, the enzyme from Herpetosiphon 
aurantiacus (phylum Chloroflexi) (Holt and Lewin 1968). H. aurantiacus is the only rvt-carrying 
bacterium with a sequenced genome that is available as a cultured strain in the ATCC collection. The 
sequenced genome of H. aurantiacus (Kiss, et al. 2011) has a single rvt copy which is located on its 
circular chromosome (GenBank Acc. No. CP000875.1: 3377924-3380284), and a close homolog is 
present in a syntenic environment in a congeneric H. geysericola (Ward, et al. 2015); however, 
genetic tools for either species are lacking. Previously, we found that expression of NcRVT, an 
enzyme from the filamentous fungus Neurospora crassa (Ascomycota; Sordariomycetes), can be 
induced by exposing the growing culture to low concentrations of antibiotics which block protein 
synthesis (blasticidin S or cycloheximide) (Gladyshev and Arkhipova 2011), thereby permitting 
purification of the native enzyme upon induction. However, our preliminary experiments did not 
detect any significant induction of native HaRVT expression by RT-PCR after blasticidin S or 
cycloheximide treatment (data not shown), indicating that such inducibility is not a general feature of 
bacterial RVT proteins. To overcome the lack of inducibility in the natural host, we chose to express 
recombinant HaRVT in a heterologous host E. coli, with a well-developed expression system which 
provides an added advantage of rapid and efficient site-directed mutagenesis. Additionally, expression 
of a recombinant protein in a heterologous system may be expected to yield a product devoid of host-
10 
 
specific templates, potentially permitting supply of external templates. To this end, we cloned a full-
length recombinant HaRVT with a C-terminal 6xHis-tag, and induced its expression in E. coli with 
IPTG. An attempt to employ the N-terminal 6xHis-tag was unsuccessful, as the resulting proteins 
were less stable and showed signs of degradation (data not shown). In addition to the full-length 
HaRVT, we also created a series of mutants either with deletion of a specific domain of interest, or 
with site-specific mutations expected to interfere with domain functions. Table 1 lists these mutants, 
which will be described in more detail in the context of domain structure presented below. 
HaRVT domain structure 
HaRVT (GenBank Acc. No. ABX05271.1) is an 89.3-kDa protein 786 aa in length, with an 
isoelectric point 5.77. As described in (Gladyshev and Arkhipova 2011), all RVTs contain the 
conserved RT1-RT7 core motifs plus the thumb subdomain. A distinctive feature that sets them apart 
from all other RTs is a large insertion loop 2a between core RT motifs 2 and 3 (Gladyshev and 
Arkhipova 2011), which in HaRVT has a cysteine close to the N-boundary and an asparagine near the 
C-boundary, and might be a remnant of an intein, i.e. protein intron (Novikova, et al. 2014). In 
addition to the core RT with intact catalytic residues, HaRVT possesses several other discernible 
domains (Fig. 2). First, it harbors an N-terminal coiled-coil spanning 29 amino acids (I12-D40), 
which is highly conserved in virtually all RVT proteins. Additionally, the region between 178-229 aa 
has four alpha helices showing weak homology to an HTH DNA-binding domain. Finally, the C-
terminal domain with no recognizable motifs comprises ~130 aa, beginning at the thumb domain 
boundary with the GGLG motif, which is shared between RVT and non-LTR retrotransposons 
(Gladyshev and Arkhipova 2011) and may act as a hinge between the core RT and the C-terminal 
domain. 
HaRVT multimerizes via the N-terminal coiled-coil domain 
We previously showed that NcRVT multimerizes in solution, forming ~1-MDa decameric 
complexes (Gladyshev and Arkhipova 2011). To find out whether HaRVT displays the same ability, 
we analysed the recombinant full-length HaRVT tagged with a C-terminal 6xHis affinity tag in E. coli 
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Rosetta 2 (DE3) strain. After cell lysis, soluble proteins were fractionated by sedimentation in a 
sucrose gradient. Position of the His-tagged protein in the gradient was identified by SDS-PAGE of 1-
ml fractions, followed by Western blotting with a His-tag-specific antibody. Extrapolation of the 
calibration curve shows that HaRVT, similarly to NcRVT, tends to multimerize, and can form up to 
octamers (Fig. 3). In contrast to NcRVT, the number of subunits in oligomers is not well defined, but 
instead varies from 1 to 8, averaging at 4-5.  
To identify domains involved in multimerization, we created an N-terminally truncated HaRVT 
mutant without the coiled-coil domain (Ha-ΔCC; Table 1). It is well known that coiled-coil domains 
can mediate oligomerization in a broad range of oligomeric states, the most common being parallel 
and antiparallel dimers, trimers, and tetramers, although higher-order oligomers are not uncommon 
(Lupas and Bassler 2016). In agreement with our expectation, the coiled-coil-deficient version lost the 
ability to multimerize, and was primarily recovered in the monomeric state (Fig. 3D). The HaRVT 
catalytic mutant (Ha-D484A), which carries a D-to-A mutation in the FVDD box of the core motif 
RT5, preserves the ability to multimerize in the same way as the full-length HaRVT (Fig. 3C). 
Unexpectedly, another HaRVT version with a mutation designed to disrupt the putative HTH-like 
DNA-binding domain (Ha-DBD) peaks in the dimer rather than the monomer range (Fig. 3E). 
Collectively, these results indicate that HaRVT oligomerizes primarily through its N-terminal coiled-
coil, but multimerization can also be modulated by additional sites within the N-terminal domain. 
HaRVT polymerizes short products in vitro in the presence of Mn2+ ions 
As a reverse transcriptase, HaRVT is expected to polymerize DNA on RNA templates. However, 
we previously showed that NcRVT displays a terminal transferase activity in vitro and can polymerize 
both NTPs and dNTPs, with a strong preference for NTPs (Gladyshev and Arkhipova 2011). This 
activity is supported by Mn2+ ions acting as a co-factor. We sought to find out whether HaRVT is also 
an active polymerase and, if so, to verify the nature of the resulting product, i.e. DNA or RNA. 
Purified recombinant HaRVT and induced natural NcRVT proteins were incubated with [α-32P]dCTP 
in the presence of 3 mM Mn2+, followed by chase with an excess of “cold” NTPs or dNTPs. We 
observed the same results with NcRVT as described in (Gladyshev and Arkhipova 2011), serving as 
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an internal control (Fig. 4). However, HaRVT displayed only the ability to polymerize dNTPs at a 
very low level, yielding short extension products (Fig. 4). This difference may be an intrinsic property 
of HaRVT, although it may also result from the presence of a C-terminal His-tag. Sucrose gradient 
fractions containing the His-tagged HaRVT protein exhibited the same activity as the IMAC purified 
protein (Supplementary Figs. S2 and S3). HaRVT mutants lacking the coiled-coil domain (Ha-ΔCC) 
or DNA-binding domain (Ha-DBD) display the same dNTP polymerization pattern as the full-length 
protein (Supplementary Figs. S3 and S4), yielding very short products after the dNTP but not NTP 
chase. Importantly, replacement of one of the catalytic aspartates in the FVDD box with alanine (Ha-
D484A) leads to complete elimination of polymerase activity of HaRVT (Supplementary Fig. S5), 
ruling out the possibility that the 32P-labeled nucleotide is simply being captured in the binding pocket 
for reasons unrelated to catalysis. 
Both HaRVT and NcRVT bind dCTP 
For all recombinant HaRVT versions, with notable exception of the D484A catalytic mutant, 
broad bands with apparent size of ca. 30 nt and 40 nt, regardless of NTP/dNTP chase, could be clearly 
detected on denaturing PAGE (Fig. 4 and Fig. 9, bands marked with asterisks). Treatment of reaction 
mixes with DNase, RNase, or 0.3 M NaOH, as well as pre-treatment of the protein with RNase, did 
not eliminate those bands and did not affect their size (Supplementary Fig. S6). However, ethanol 
precipitation of the reaction mix removes those bands completely, which is indicative of their 
proteinaceous nature (Supplementary Figs. S2 and S6). To test this hypothesis, we separated the same 
reaction mixes, but without Proteinase K treatment, by SDS-PAGE. Indeed, bands corresponding to 
full-length HaRVT in size, and showing the presence of His-tagged protein after Western blot 
hybridization, were clearly detected (Figs. 5 and 6). Chasing the reaction with dNTPs slightly 
increases the size of the protein band, indicating that more than one deoxynucleotide becomes bound 
to the protein, i.e. that HaRVT-dCMP represents an initiation complex that can be elongated (Fig. 6, 
left panels). Pre-treatment of HaRVT with RNase shows no effect on the priming reaction, and neither 
it is affected by post-treatment with DNase or RNase (Fig. 6). 
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When we performed the priming assay with sucrose gradient fractions containing full-length 
HaRVT, rather than IMAC-purified protein, the signal is visible only for the protein band 
corresponding to HaRVT, but not for any other protein in the mix (Fig. 6). Thus, for further assays we 
used sucrose gradient fractions of the corresponding mutants, in order to confirm that no protein other 
than HaRVT derivatives can form nucleotide-protein linkages. Both mutant HaRVT versions lacking 
the multimerization pattern (Ha-ΔCC and Ha-DBD) display binding of labelled dCTP, indicating that 
neither the coiled-coil nor the putative DNA-binding domain are involved in priming (Supplementary 
Fig. S7). The reaction was performed in the presence of 3 mM Mn2+, and the lack of a DNA-binding 
domain or the absence of any natural template attached to HaRVT is not expected to play a role in 
priming, since the initiation stage of polymerization may be template-independent in the presence of 
Mn2+ ions, as was shown for HBV RT (Urban, et al. 1998). Importantly, the catalytic mutant Ha-
D484A, although clearly visible on a Western blot, shows no trace of protein-bound nucleotides, 
indicating that the addition of the first nucleotide is performed by the core catalytic RT domain of 
HaRVT (Fig. 6, A and D). As with the sucrose gradient fractions of Fig. 6, the IMAC-purified Ha-
D484A mutant shows no signs of a dCTP-HaRVT bond formation (data not shown), reiterating the 
catalytic nature of dCTP-protein linkage. 
Interestingly, the native NcRVT from N. crassa, which was induced by blasticidin and purified 
as in (Gladyshev and Arkhipova 2011), also shows the in-gel labeling pattern consistent with 
formation of a covalent protein-nucleotide linkage (Supplementary Fig. S8), indicating that the ability 
for protein priming may be a general RVT feature. Nevertheless, this activity in NcRVT may be 
outcompeted by formation of long non-templated chains, with only trace amounts of amino acid-
dCMP products visible in Fig. 4 (right panel), as well as in Fig. 3D from (Gladyshev and Arkhipova 
2011). 
Effect of different cations on HaRVT priming activity 
We checked the effect of Mg2+ and Mn2+ on protein-nucleic acid linkage. Attachment of labeled 
dCTP to HaRVT can be detected at low levels in the absence of divalent cations (Fig. 7), probably 
because of residual ions remaining after protein purification. However, addition of 3 mM Mg2+ or 3 
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mM Mn2+ dramatically increases the amounts of dCMP linked to HaRVT (Fig. 7). Substitution of 100 
mM NaCl with 75 mM or 50 mM KCl does not significantly affect the priming ability (compare Fig. 
4 using Buffer A with 100 mM NaCl to Fig. 9 using priming buffer with 50 mM KCl). The effect of 
monovalent cations on HaRVT remains a subject for further investigation, since it could affect 
conformation of putative natural templates. 
HaRVT and NcRVT may be linked to dCTP through a tyrosine residue in the C-terminal domain 
Since protein priming could be initiated by a hydroxyl group-containing serine, threonine, or 
tyrosine residue of a protein (Salas, et al. 1996), it was of interest to find out which domain carries the 
priming residue, and which amino acid is used by RVT for priming. It is known that the 
phosphotyrosine linkage is resistant to 1 M hot KOH treatment, but the phosphoserine and 
phosphothreonine linkages are not (Cooper and Hunter 1981; Galligan, et al. 2011). After KOH 
treatment at 65°C, both HaRVT and NcRVT still show the labeled nucleotide linked to the protein, 
indicating that both may use a Tyr residue to prime polymerization (Fig. 6C and Supplementary Fig. 
S8), and narrowing the search to a conserved Tyr. Comparison of HaRVT and NcRVT protein 
sequences revealed four conserved Tyr residues: Y335, located in the loop region between the RT2 
and RT3 motifs of the RT domain; Y626, located in the αJ helix of the RT thumb; and Y741 and 
Y749, both located in the C-terminal domain of HaRVT (Fig. 2; numbering refers to HaRVT protein). 
We created the corresponding HaRVT mutants, substituting each Tyr with the structurally similar Phe 
lacking the hydroxyl group (Table 1; Ha-Y335F, Ha-Y626F, and Ha-YF). Since Y741 and Y749 are 
located very close to each other and could potentially substitute each other for protein priming 
purposes, we have mutated both of them simultaneously to avoid possible compensatory effects (Fig. 
2C). As shown in Fig. 8A, very little labeling was observed in the double-Tyr mutant Ha-YF, 
suggesting that the C-terminal domain may serve the function of the so-called terminal protein (TP) 
(Salas 1991) (see Discussion). Nevertheless, it is also possible that even the conservative Tyr-to-Phe 
replacement in the C-terminus negatively affects catalysis. We cannot rule out the involvement of a 
loop tyrosine either, since there are three other, less conserved Y296, Y308 and Y361 residues in loop 
2a which may potentially substitute for Y335. 
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Finally, we sought to find out whether the reduced activity of the Ha-YF mutant could be rescued 
in trans by addition of the catalytically dead enzyme with an intact C-terminus. However, combining 
Ha-D484A with Ha-YF did not improve labeling, indicating that trans-complementation does not 
occur (Fig. 8B). Overall, our results are consistent with the view that the catalytic center is in the 
closed conformation provided by the greatly extended loop 2a (Zhao, et al. 2017) and is largely 
inaccessible to external substrates, but is capable of adding dNTP onto suitable hydroxyl groups in the 
vicinity of the catalytic center (either short oligos captured during enzyme preparation, or accessible 
hydroxyls in the protein itself).    
HaRVT displays a strong preference for dCTP 
Usually, the choice of nucleotide for protein priming is directed by the 3’ end of a specific 
template (Salas, et al. 1996). Even when a recombinant protein expressed in a heterologous system is 
expected to be free of a host-specific template, it may still utilize a template bearing some 
resemblance to the natural template. To find out whether recombinant HaRVT displays any nucleotide 
preferences, we incubated the HaRVT protein with [α-32P]dCTP, and then chased with dNTP, NTP, or 
each of the four nucleotides (Fig. 9). It is clearly seen that addition of dCTP yields a prominent 13-nt 
band, which is also visible at a much lower intensity with dNTP chase. This result indicates that 
HaRVT strongly prefers to incorporate dCTP over all other dNTPs, which may in turn hint at the 
presence of a G-rich template in the natural host. Nevertheless, in the presence of 3 mM Mg2+, [α-
32P]UTP could also attach to HaRVT protein to a certain extent (Supplementary Fig. S9). However, in 
contrast with [α-32P]dCTP, the [α-32P]UTP-amino acid adducts are barely visible (Supplementary Fig. 
S10), even in the presence of 3 mM Mn2+, consistent with the preference for deoxy- over 
ribonucleotides. In this experiment, when dCTP was used for chase, a diffuse area corresponding to 
putative extension products appears on denaturing PAGE, again indicating preference for 
deoxycytidine incorporation (Supplementary Fig. S10).  
Overall, our findings contrast sharply with in vitro properties of NcRVT, which does not strongly 
discriminate between individual bases and sugars, in fact showing a slight preference for NTP 
incorporation over dNTP, acting in a non-templated fashion. While the underlying reasons for base 
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discriminations may vary, we favor the hypothesis that the preference for dCTP displayed by HaRVT 
may be indicative of its ability to perform RNA-dependent DNA polymerization, as expected of an 
RT, and that it may be explained by affinity for a G-rich RNA template in its natural host. 
Discussion 
RVT: the only RT with cross-domain presence 
RVTs are encoded by chromosomal genes and can be found in all kingdoms of life, implying a 
biological function applicable to both prokaryotes and eukaryotes. Their prevalence in the fungal 
kingdom (as per our most recent inventory, only 30 out of more than 250 RVT sequences did not 
originate from fungi), and their conspicuous absence from most metazoans, except for collembolan 
insects and bdelloid rotifers, seems to favour the possibility that RVTs act autonomously and can 
occasionally undergo horizontal transfers without undermining their biological function.  
The presence of rvt genes across the major domains of life, Eukarya and Bacteria, may be 
regarded as one of their most unusual properties. Every other known RT type can be assigned either to 
Bacteria/Archaea, or to Eukarya. In our initial study (Gladyshev and Arkhipova 2011), only a single 
sequenced bacterium (and two environmental samples) harboured an rvt gene, which could be most 
parsimoniously explained by a single eukaryote-to-prokaryote horizontal transfer event. In this work, 
we conducted an extensive search of prokaryotic genomes and metagenomes, and identified six 
sequences of assigned bacterial origin and five environmental metagenome/metatranscriptome 
sequences of presumably bacterial origin, which displayed clear homology to rvt. The prokaryotic 
sequences, which come from diverse phyla (Chloroflexi, Cyanobacteria, Bacteroidetes, 
Planctomycetes), exhibit more similarity to each other than to their eukaryotic counterparts. Thus, the 
monophyly of bacterial rvt genes may be best interpreted in terms of their shared ancestry, with 
intradomain rather than interdomain horizontal exchange, combined with a strong trend for 
elimination from bacterial genomes. Indeed, three bacterial contigs harbored only partial rvt 
fragments.  
The unusual properties of RVTs may bear relevance to the broader question of biological 
significance of reverse transcription in living cells. Reverse transcription is usually utilized by viruses, 
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retrotransposons, or retroplasmids, i.e. serves the proliferative needs of autonomous genetic elements 
which are not involved in major cellular processes. TERT is an important exception which performs 
chromosome end maintenance in most eukaryotes by reverse-transcribing a highly-specialized 
unlinked RNA template. RVTs represent the only other exception, however their cellular role(s) 
remain unknown. It is worth noting that in ascomycete genomes, two out of five RVT lineages (L and 
M, Fig. 1) underwent further specialization associated with apparent loss of reverse transcription, 
which is manifested in the loss of catalytic residues by all members of the lineage (data not shown). 
The N. crassa genome harbors a single lineage (N) coding for a non-essential ORF, which retains all 
of the catalytic motifs required for activity, and can be purified as a decamer (Gladyshev and 
Arkhipova 2011). 
RVT as a multimer  
An interesting feature of RVT proteins, conserved across different kingdoms, is its ability to 
form multimers. Many polymerases, including RTs, are known to act as dimers, although in some 
cases they can also act as monomers, e.g. different retroviral RTs, or TERTs from certain species 
(Nowak, et al. 2013; Sandin and Rhodes 2014). In principle, multimerization above the dimeric state 
could be a mechanism preventing uncontrolled RVT action in the host. On the other hand, many viral 
RNA-dependent RNA polymerases (RdRPs) can form oligomers via an N-terminal domain and even 
form lattices without loss of functionality (O'Reilly and Kao 1998; te Velthuis 2014; Ferrer-Orta, et al. 
2015), although they lack any coiled-coil motifs. Neither are such motifs typically found in RTs. 
Computational predictions of the oligomeric state for RVT proteins by Logicoil (Vincent, et al. 2013) 
can vary, but the most probable state is usually a tetramer or a trimer (data not shown). Our results 
identify the N-terminal coiled-coil motif of HaRVT as the primary determinant for multimerization, 
since its removal shifts the protein from the multimeric to the monomeric state. In addition, the 
oligomerization process can also be affected by a mutation in the presumptive DNA-binding domain, 
which may provide an extra contact surface. Priming activity, however, appears to be unaffected in 
the Ha-ΔCC mutant. While the functional significance of multimerization in vivo remains to be 
determined, its conservation in all RVTs, except for the M lineage lacking the catalytic aspartate in 
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motif A, suggests a connection to RVT enzymatic properties. We hypothesize that multimerization 
may serve to prevent RVT from acting on host templates in an uncontrollable fashion: since the 
putative DBD is adjacent to a region also prone to coiled-coil formation (Fig. 2B), it may become 
exposed upon unzipping of the coiled-coils and made available for target binding. 
Protein priming by reverse transcriptases 
Our data indicate that RVT may be the first case of a chromosomal RT with protein priming 
ability. It is still a mystery why the product of a domesticated RT gene would utilize protein priming, 
which has so far been reserved for virus-borne, plasmid-borne, or mobile element-associated 
polymerases, the sole exception being the maintenance of linear chromosomes in the bacterial genus 
Streptomyces (Yang, et al. 2002). Use of a protein to prime polymerization, especially in eukaryotic 
species with enough options for solving the problems with replication of linear DNA ends, would be 
very unusual and may imply a non-trivial function. 
Most polymerases, including RTs, require a primer, i.e. a free 3’-OH group, with the exception 
of de novo initiation by a mitochondrial plasmid-encoded RT in Neurospora (Chen and Lambowitz 
1997) and the non-canonical RdRP activity of TERT (Maida, et al. 2016), although de novo initiation 
is often utilized by viral and cellular RdRPs (van Dijk, et al. 2004). Primers are classified into four 
groups, viz. 1) 3’ hydroxyl termini of DNA complementary to the RNA template; 2) nascent RNA 
chains; 3) tRNA molecules that anneal to specific sequences in the RNA genomes, as in retroviruses; 
and 4) deoxyribonucleoside monophosphate which is covalently attached to a specific serine, 
threonine, or tyrosine residue of a protein through its hydroxyl group (Salas, et al. 1996). The latter 
mode, called protein priming, is utilized by bacteriophages (e.g. φ29, PRD1, Cp-1); plasmids (e.g. 
pGKLl, pGKL2, pFOXC); certain animal viruses with linear DNA genomes (e.g. adenovirus); 
reverse-transcribing viruses such as hepadnaviruses (e.g. hepatitis B virus, or HBV); and bacteria 
from the genus Streptomyces with linear chromosomes (Salas, et al. 1996). Thus, protein priming can 
allow full autonomous replication of linear DNAs that cannot form circular structures through 
cohesive ends, hairpin structures at their termini, etc.  
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The mechanism of protein priming in DNA replication was reviewed in (Salas 1991). In general, 
specific initiation proteins interact with the origin of replication, initiating the unwinding of the 
double helix and exposing single-stranded DNA. The molecule of the terminal protein (TP) forms a 
complex with a specific DNA polymerase, and interacts with the origin of replication via recognition 
between TP and specific sequences at the DNA end. In the presence of the dNTP corresponding to the 
5’-terminus, DNA polymerase catalyzes formation of a covalent bond between the dNMP and the OH 
group of a specific serine, threonine or tyrosine in the TP. After that, chain elongation occurs by a 
strand-displacement mechanism, with the concomitant removal of the initiation proteins and binding 
of the single-strand binding protein to the parental single-strand that is being displaced. The whole 
process also needs a topoisomerase or helicase activity. In most cases (e.g. phi29, adenovirus), TP is 
represented by a separate protein, but TP can also be located on the same polypeptide chain with the 
polymerase, as in HBV (Salas 1991). 
So far, protein priming is not known to be exploited by eukaryotic host polymerases, and it is 
still unclear what cellular function could possibly utilize this essentially viral mechanism of initiation 
of polymerization. The only protein-primed RT-related protein with a biological function is the 
plasmid-borne AbiK from the bacterium Lactococcus lactis, which also exhibits terminal transferase 
but not RT activity (Wang, et al. 2011). Unlike RVT, AbiK is encoded by a native plasmid, and 
implies a non-replicative role for a polymerase in abortive phage infection, although the exact 
mechanism of its action remains unknown. A linear mitochondrial pFOXC plasmid in the fungus 
Fusarium oxysporum encodes an RT which is thought to employ protein priming for self-replication, 
although it can also initiate DNA synthesis by using snapped-back RNA templates or loosely 
matching DNA primers (Galligan, et al. 2011). The final and the best-studied example of RT utilizing 
protein priming is provided by hepadnaviruses, such as HBV. The HBV viral polymerase contains 
four domains, including TP (~175 aa), spacer, RT and RNase H. In HaRVT, the presumptive TP 
domain is also located on the same polypeptide chain with RT, while φ29 or other DNA viruses use a 
TP that is separate from polymerase. Importantly, we show that substitution of the catalytic aspartate 
to alanine in HaRVT abolishes formation of the protein-nucleotide bond, demonstrating that the RT 
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catalytic domain of RVT is involved in initiation of polymerization. However, additional modes of 
initiation cannot be ruled out, since the linkage is detectable only in radioactive assays and may be 
present in minor quantities, and the bulk of the enzyme molecules did not reveal the expected product 
in a mass-spec analysis of a tryptic digest (data not shown), as was also the case for pFOXC (Galligan, 
et al. 2011) (for AbiK, mass spec analysis was not performed). 
The presumptive TP domain in HaRVT is relatively small (<130 aa), although in eukaryotic 
RVTs the respective domain can reach up to 200 aa in length. The TPs of Streptomyces are about 185 
aa long and are believed to be the smallest TPs (Yang, et al. 2002), while TPs of the φ29-like phages 
are 230–270 aa in length, and the adenoviral TPs are the largest (600–660 aa, derived from even 
larger precursors). Our finding that tyrosine replacement with a chemically similar phenylalanine in 
the C-terminal domain of HaRVT results in drastic reduction of the radioactive signal suggests the 
involvement of a phosphotyrosine linkage, as initially inferred from KOH treatment, although it is 
still possible that even a chemically similar replacement in the C-terminus leads to a conformational 
change affecting functionality in an unpredictable way. While Y741 is shared between HaRVT and 
NcRVT, the Y749 residue exhibits better overall conservation (Fig. 2C). Nevertheless, both residues 
are conserved in most RVTs, with very few exceptions. In the future, high-resolution structural 
studies of the purified HaRVT should demonstrate which residues are better positioned for priming. 
Modes of polymerization 
In contrast to the fungal NcRVT, which prefers to polymerize NTPs but can also polymerize 
dNTPs, we find that the bacterial HaRVT polymerizes mostly dNTPs, as may be expected for an RT-
related enzyme. Further experiments should clarify whether the observed difference in biochemical 
properties is related to functional differences between bacterial and fungal proteins, which may have 
undergone lineage-specific changes. A notable difference is also the extremely short length of 
polymerization products produced by HaRVT, while NcRVT synthesizes up to 80-nt products 
(Gladyshev and Arkhipova 2011). 
For HBV, the initiation step of polymerization, which also yields very short products, occurs in 
the presence of either Mg2+ or Mn2+ divalent cations (Lin, et al. 2008). However, its terminal 
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transferase activity, i.e. template-independent polymerization, requires Mn2+, which promotes 
conformational changes in the protein, while Mg2+ does not provide a sufficient degree of freedom 
(Jones and Hu 2013). Both NcRVT and HaRVT exhibit terminal transferase activity in the presence 
of Mn2+. In the presence of Mg2+, NcRVT shows a significant decrease in length and amounts of 
polymerization products when compared to Mn2+ (Gladyshev and Arkhipova 2011). The same 
apparently applies to HaRVT, with the difference that it yields extremely short products, which are 
difficult to visualize even in high-percentage polyacrylamide gels. In the absence of a natural template, 
HaRVT may be unable to complete the transition from the priming mode to the elongation mode in 
vitro, or perhaps to perform template jumps, giving rise to products of very limited length, which are 
protected from the action of DNase, as is also seen in HBV. The HBV RT synthesizes very short (up 
to 10 nt) DNA oligomers, either in a templated or a non-templated Mn2+-dependent fashion, and then 
undergoes a conformational change to enter the “generic” elongation mode, using the viral RNA 
template to yield longer DNase-sensitive products (Jones and Hu 2013). NcRVT, in contrast, can 
apparently enter the elongation mode and proceed as a terminal transferase to yield much longer 
nucleotide chains, in a manner reminiscent of AbiK (Wang, et al. 2011). It is worth mentioning that 
the terminal transferase activity in the presence of Mn2+ can also be exhibited by TERTs (Lue, et al. 
2005) and by a few other RTs, and may therefore represent one of the ancestral RT activities. 
The most logical next step towards understanding RVT biological function would be 
identification of a cellular template for the enzyme in its native host. While overexpression in a 
heterologous host is not expected to yield an enzyme associated with a specialized host template, our 
data indicate that HaRVT favors attachment of deoxycytidine, consistent with the preferred template 
RNA starting with guanosine, and its strong preference for dCTP incorporation implies that such 
template may be G-rich. Interestingly, NcRVT showed preference for CTP and TTP, but was unable 
to incorporate GTP (Gladyshev and Arkhipova 2011), which may fit the concept of a G-rich template. 
It is of note that neither HaRVT nor NcRVT were capable of in vitro extension of several 
exogenously supplied primer-template combinations, which were readily extended by commercially 
available RTs (data not shown). We hypothesize that the extended loop region, which upon modelling 
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blocks the entrance to the catalytic center, may serve as the accessibility gate for exogenous templates 
and may undergo conformational changes in vivo to regulate the catalytic properties.  
If we were to make a statement that rvt is the rarest bacterial gene, it would not be far from truth. 
The fact that, of all sequenced bacterial genomes, now in the hundreds of thousands, only a few 
representatives harbor rvt genes indicates that these RTs in bacteria are highly specialized and can be 
lost at astonishingly high rates. In addition to template-dependent polymerization, non-canonical rvt 
functions, such as modulation of protein activity by deoxynucleotydilation, could be entertained. It is 
also possible that the activities observed in vitro represent only a subset of all possible RVT activities, 
of which protein priming may be just an evolutionary remnant. We hope that further studies in natural 
hosts will uncover more canonical RNA-dependent polymerization properties and, eventually, a 
biological function of the enigmatic RVT proteins. 
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Fig. 1. A neighbour-joining phylogram of 200 representative amino acid RVT sequences (listed by 
clade in Supplementary Dataset 1). Clade support values exceeding 50% are shown; clade topology is 
unchanged in a maximum-likelihood phylogram (not shown). Catalytically inactive clades are marked 
by asterisks; representative genera are given in parentheses. Clades were compressed in MEGA7.0.18 
(Kumar, et al. 2016) and color-coded by taxonomy: gray, ascomycetes; purple, basidiomycetes; 
brown, basal fungi; olive, oomycetes; green, mosses; magenta, insects; red, rotifers; cyan, bacteria. 




Fig. 2. Domain structure of HaRVT protein. (A) Diagram of the full-length HaRVT. Intertwined 
helices, coiled-coil motif (CC); yellow hexagon, putative HTH DNA-binding domain (DBD); gray 
rectangle, core RT with motifs 1-7 (indicated). Shown are the positions of the catalytic D,DD triad 
(with the mutagenized catalytic aspartate in the RFVDD motif underlined); the GGLG motif shared 
between RVT and non-LTR retrotransposons; the C and N residues at the loop boundaries; and the 
conserved Y residues mentioned in the text. Amino acid conservation at each position, calculated 
from an alignment of 200 RVT sequences, is plotted on the top, with predicted secondary structure 
elements such as alpha-helices (red) and beta-sheets (green) shown underneath. The yellow trapezoids 
are guiding to the respective regions in panels B and C. (B) Probability of coiled-coil formation in the 
alignment of 200 RVT N-termini, as predicted by COILS/ PCOILS (Alva, et al. 2016); according to 
predictions in (A), the N-terminal region harbors only α-helices. (C) Fragment of HaRVT and NcRVT 
secondary structure prediction by Phyre2 showing the C-terminal domain with two conserved Tyr 







Fig. 3. HaRVT multimerization. (A) Relative positions of HaRVT complexes and molecular mass 
standards in sucrose gradient fractions. Protein standards are abbreviated as follows: Tg, 
thyroglobulin, 660 kDa; Cat, catalase, 250 kDa; ADH, alcohol dehydrogenase, 141 kDa; BSA - 
bovine serum albumin, 66.5 kDa. Positions of HaRVT monomer (90.1 kDa), dimer, tetramer, 
hexamer, octamer, and decamer in the gradient, as expected from the standard curve, are indicated 
schematically by the number of subunits on the graph. Distribution of fractions containing HaRVT, 
Ha-D484A, Ha-DBD, and truncated Ha-ΔCC (87.3 kDa as a monomer), as determined by Western 
blotting, is shown under the graph. (B-E) Distribution of HaRVT proteins in sucrose gradient 
fractions. Numbers on gel lanes correspond to fraction numbers. The diagram of each protein mutant 
(top) and western blot with anti-His-tag antibody (bottom) are shown for HaRVT (B), Ha-D484A (C), 




Fig. 4. Nucleotidyltransferase activity of HaRVT and NcRVT. Proteins were pre-incubated with [α-
32P]dCTP in the presence of 3 mM Mn2+. Reactions were chased with NTPs (“N”), dNTPs (“dN”) or 
nuclease-free water as a control (“‒”). After proteinase K treatment, reactions were separated on 12% 
denaturing PAGE. M, marker. Asterisks denote [α-32P]dCTP bound to amino acid(s). Arrows show 




Fig. 5. Formation of protein-nucleotide linkage by purified recombinant HaRVT. Purified HaRVT 
(2.5 µg) was incubated with [α-32P]dCTP in the presence of 3 mM Mg2+, and the reaction was 
separated on 10% SDS-PAGE. M, marker. Phosphor image (left), same gel after staining (middle), 




Fig. 6. Protein priming activity of recombinant HaRVT variants. Identical sucrose gradient fractions 
(#23 in Fig. S1A and S1B) for HaRVT (left) and Ha-D484A (right), enriched with recombinant His-
tagged protein, were treated as denoted on the top, and separated on 10% SDS-PAGE. (A) Phosphor 
image. (B) Stained gel shown in A. (C) Phosphor image of the same gel as in A and B for HaRVT 
after alkali treatment. After staining and imaging, the gel was dried, incubated in 1 M KOH at 55ºC 
for 2 h, neutralized with four changes of 10% acetic acid, 10% isopropanol, and dried for phosphor 
imaging. (D) Western blot with His-tag specific antibody of sucrose gradient fractions used in HaRVT 




Fig. 7. Effect of divalent cations on HaRVT protein priming activity. The purified HaRVT protein 
was incubated with [α-32P]dCTP (“+[α-32P]dCTP”) without divalent ions (“-”) and in the presence of 
3 mM Mg2+ (“Mg”) or 3 mM Mn2+ (“Mn”); the protein without addition of [α-32P]dCTP is shown as a 
control. Reactions were separated on 10% SDS-PAGE, stained with Coomassie stain (A) and 
analyzed by phosphor imaging (B). M, marker. 
 
Fig. 8. Protein priming assays of recombinant HaRVT. Purified proteins were incubated with [α-
32P]dCTP in the presence of 3 mM Mg2+, and reactions were separated on 10% SDS-PAGE. Arrows 
point at the HaRVT band. M, marker. (A) Analysis of HaRVT with Y-to-F substitutions. Residues 
conserved between HaRVT and NcRVT were subjected to mutagenesis as follows: Ha-Y335F; Ha-
Y626F; Ha-YF (Y741F, Y749F). Phosphor image (top), same gel after staining (middle), and Western 
blot with His-tag specific antibody (bottom) are shown. (B) Assay for trans-complementation of 
protein priming activity in Ha-YF and Ha-D484A mutants compared with HaRVT. Phosphor image 
(top) and the same gel after staining (bottom) are shown. (C)  Western blot with His-tag specific 




Fig. 9. Nucleotide preferences of HaRVT. Protein was pre-incubated with [α-32P]dCTP in the 
presence of 3 mM Mn2+. Reactions were chased with NTPs (“+N”), ATP (“+A”), CTP (“+C”), GTP 
(“+G”), UTP (“+U”), dNTPs (“+dN”), dATP (“+dA”), dCTP (“+dC”), dGTP (“+dG”), dTTP (“+dT”) 
or nuclease-free water (“control”). After proteinase K treatment, reactions were separated on 20% 






Table 1. HaRVT recombinant proteins. 
 
 
Protein_ID Description of mutants Length, aa MW, kDa pI 
HaRVT-N HaRVT, N-terminal 6xHis-Tag (wild-type) 799 90.7 5.97 
HaRVT HaRVT, C-terminal 6xHis-Tag (wild-type) 792 90.1 5.93 
Ha-ΔCC HaRVT, E16_D40del (coiled-coil mutant) 767 87.3 6.06 
Ha-D484A HaRVT, D484A (catalytic mutant) 792 90.1 5.97 
Ha-DBD HaRVT, M211_A216delins GPGPGP (DBD mutant) 792 89.8 5.88 
Ha-Y335F HaRVT, Y335F (tyrosine mutant, loop) 792 90.1 5.93 
Ha-Y626F HaRVT, Y626F (tyrosine mutant, thumb) 792 90.1 5.93 
Ha-YF HaRVT [Y741F;Y749F] (tyrosine mutant, C-term.) 792 90.1 5.93 
 
